(2S)-1-FLUORO-3-((2-(6-METHYL-3-PYRIDYL)-6-QUINOLYL)OXY)PROPAN-2-OL

Name: (2S)-1-FLUORO-3-((2-(6-METHYL-3-PYRIDYL)-6-QUINOLYL)OXY)PROPAN-2-OL in Parkinson Disease
Creator: Floatz
License: https://terminal.floatz.ai/terms

Parkinson Disease

Anhui Provincial HospitalSmall moleculeActive

28/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 65/ 100

Competitive context

255 Active assets in the Parkinson Disease cohort.

Asset / Sponsor	Phase	Rating
Safinamide Zambon SpA	Phase 4	A
Cvt-301 Acorda Therapeutics	Phase 3	A
Istradefylline Georgetown University	Phase 4	BBB
Tvp-1012 Guangzhou Henovcom Bioscience Co. Ltd.	Phase 4	BBB
Pardoprunox Abbott Products	Phase 3	BBB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →